Cardiovascular disease (CVD) and autoimmune diseases (ADs) are the first and third
highest causes of death in the USA, respectively. Men have an increased incidence of the …

Objective Cardiovascular disease (CVD) risk is elevated in patients with systemic lupus
erythematosus (SLE) and diabetes mellitus (DM), but whether risk of CVD in patients with …

Objective. Premature atherosclerosis in patients with SLE is partially explained by traditional
risk factors; therefore, we aimed to identify lupus-related risk factors for coronary artery …

Objective. To analyze the mortality profile related to systemic lupus erythematosus (SLE) in
the state of São Paulo, Brazil. Methods. For the 1985–2007 period, we analyzed all death …

The brain and nervous system are important targets for immune-mediated damage in
systemic lupus erythematosus (SLE), resulting in a complex spectrum of neurological …

Systemic lupus erythematosus (SLE) is an autoimmune disorder characterized by a
constellation of cardiovascular (CV) and non-CV manifestations. Even though CV …

Objective: To identify accurate occurrence and risk of cardiovascular (CV) events (stroke and
myocardial infarction [MI]) in patients with systemic lupus erythematosus (SLE). Methods …

Recent discoveries have placed increased emphasis on the immunology of atherosclerotic
cardiovascular disease. Understanding the factors that drive the increased risk for …

Objective An association between 25‐hydroxyvitamin D (25 [OH] D; vitamin D) deficiency
and increased cardiovascular (CV) risk factors and CV disease (CVD) has been shown in …

Objective Participants in the Atherosclerosis Prevention in Paediatric Lupus Erythematosus
(APPLE) trial were randomised to placebo or atorvastatin for 36 months. The primary …